All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
|
|
|
|
|
|
|
|
FMI / Foundation Medicine, Inc.
|
|
|
|
|
|
|
|
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
PTN / Palatin Technologies, Inc.
|
|
|
|
|
|
|
|
CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
OSIR / Osiris Therapeutics, Inc.
|
|
|
|
|
|
|
|
NBRV / Nabriva Therapeutics Plc
|
|
|
|
|
|
|
|
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
|
|
|
|
|
|
|
|
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
|
|
|
|
|
|
|
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GNMX / Aevi Genomic Medicine, Inc.
|
|
|
|
|
|
|
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
032420AC5 / Anacor Pharmaceuticals Inc. Bond 2.0% 15 OCT 2021
|
|
|
|
|
|
|
|
FLXN / Horizon Funds - Horizon Flexible Income ETF
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
DMTX / Dimension Therapeutics, Inc.
|
|
|
|
|
|
|
|
Arrowhead Research Corp.
/ (042797209) |
|
|
|
|
|
|
|
375558AP8 / Gilead Sciences, Inc. Bond 1.625% 5/1/16
|
|
|
|
|
|
|
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
JUNO / Juno Therapeutics, Inc.
|
|
|
|
|
|
|
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
|
|
|
|
|
|
|
|
451731103 / Ignyta, Inc.
|
|
|
|
|
|
|
|
IMDZ / Immune Design Corp.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
|
|
|
|
|
|
|
|
MDWD / MediWound Ltd.
|
|
|
|
|
|
|
|
ECYT / Endocyte, Inc.
|
|
|
|
|
|
|
|
BLPH / Bellerophon Therapeutics, Inc.
|
|
|
|
|
|
|
|
30161QAC8 / Exelixis, Inc. Bond
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
220480AB3 / Amrn 3.5 1/32 Bond
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
AAAP / Advanced Accelerator Applications S.A
|
|
|
|
|
|
|
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
QLGN / Qualigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
STML / Stemline Therapeutics, Inc.
|
|
|
|
|
|
|
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
CYTR / LadRx Corp
|
|
|
|
|
|
|
|
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
NBSE / NeuBase Therapeutics, Inc.
|
|
|
|
|
|
|
|
0HBB / Aimmune Therapeutics Inc
|
|
|
|
|
|
|
|
DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
|
|
|
|
|
|
|
|
BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
MCRB / Seres Therapeutics, Inc.
|
|
|
|
|
|
|
|
/ Achaogen Inc
|
|
|
|
|
|
|
|
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
|
|
|
|
|
|
|
|
US189464AB64 / Clovis Oncology, Inc. 2.5% 9/15/2021
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
|
|
|
|
|
CERS / Cerus Corporation
|
|
|
|
|
|
|
|
IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
ACOR / Acorda Therapeutics, Inc.
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
|
|
|
|
|
LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|